Year: 2024
Type: article
Abstract: susan fitzgerald A m i d a n ever -g row i ng demand for weight loss drugs comes a new study that suggests that semaglutide, marketed as Ozempic and Wegovy, may increase the risk for a form of blindness.for semaglutide, but further study is required to assess causality," concluded the study, published online July 3 in JAMA Ophthalmology.Joseph F. Rizzo III, MD, endowed professor of ophthalmolog y at Massachusetts Eye and Ear and Harvard, said that although the study does not prove cause and effect, "we feel very comfortable with the results we obtained, and we are thinking about
Source: Neurology Today
Author: Susan Fitzgerald
Language: English
Topic: Drug-Induced Ocular Toxicity
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4401618002